Qube Research & Technologies (QRT)’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1
Closed -$54 – 3697
2024
Q2
$54 Hold
1
– – ﹤0.01% 3498
2024
Q1
$70 Hold
1
– – ﹤0.01% 4200
2023
Q4
$83 Buy
+1
New +$97 ﹤0.01% 4038

Other funds holding MTRI

Qube Research & Technologies (QRT)'s MTRI Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2024, closing a stake of 1 share — an estimated $54 sold.

Qube Research & Technologies (QRT) first reported a position in MTRI in Q4 2023 and held it in 3 quarters. The position peaked at $83 in Q4 2023. 9 funds tracked by Wall St. Rank hold MTRI as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1 Mentari Therapeutics, Inc. Common Stock share in Q3 2024, an estimated $54.
  • Qube Research & Technologies (QRT) first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Mentari Therapeutics, Inc. Common Stock position peaked at $83 in Q4 2023.
  • 9 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.